Harrington KJ, Rosenberg AJ, Yang MH, Geiger JL, et al. Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study. Oral Oncol 2025;171:107791.
PMID: 41275660